IL143920A0 - 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same - Google Patents

3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL143920A0
IL143920A0 IL14392099A IL14392099A IL143920A0 IL 143920 A0 IL143920 A0 IL 143920A0 IL 14392099 A IL14392099 A IL 14392099A IL 14392099 A IL14392099 A IL 14392099A IL 143920 A0 IL143920 A0 IL 143920A0
Authority
IL
Israel
Prior art keywords
heteroarylidenyl
same
pharmaceutical compositions
compositions containing
indolinone derivatives
Prior art date
Application number
IL14392099A
Original Assignee
Sugen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen Inc filed Critical Sugen Inc
Publication of IL143920A0 publication Critical patent/IL143920A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
IL14392099A 1998-12-31 1999-12-30 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same IL143920A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11431398P 1998-12-31 1998-12-31
PCT/US1999/031232 WO2000038519A1 (en) 1998-12-31 1999-12-30 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy

Publications (1)

Publication Number Publication Date
IL143920A0 true IL143920A0 (en) 2002-04-21

Family

ID=22354480

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14392099A IL143920A0 (en) 1998-12-31 1999-12-30 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same

Country Status (10)

Country Link
EP (1) EP1139754A4 (en)
JP (1) JP2002533360A (en)
KR (1) KR20010108063A (en)
CN (1) CN1356872A (en)
AU (1) AU760964B2 (en)
BR (1) BR9916735A (en)
CA (1) CA2357042A1 (en)
IL (1) IL143920A0 (en)
MX (1) MXPA01006742A (en)
WO (1) WO2000038519A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
ES2367007T3 (en) * 1999-11-24 2011-10-27 Sugen, Inc. INDONINABLE DERIVATIVES OF INDOLINONA AND ITS USE AS PTK BINDERS.
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
EP1255752B1 (en) * 2000-02-15 2007-08-08 Sugen, Inc. Pyrrole substituted 2-indolinone protein kinase inhibitors
EP1278518B1 (en) * 2000-02-28 2006-11-08 Pfizer Enterprises SARL Synergistic combination for the treatment of colorectal cancer
MY128449A (en) 2000-05-24 2007-02-28 Sugen Inc Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
US6706709B2 (en) 2000-06-02 2004-03-16 Sugen, Inc. Indolinone derivatives as protein kinase/phosphatase inhibitors
US7312237B2 (en) 2001-03-14 2007-12-25 Bristol-Myers Squibb Co. Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
US6599902B2 (en) 2001-05-30 2003-07-29 Sugen, Inc. 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
AR038957A1 (en) * 2001-08-15 2005-02-02 Pharmacia Corp COMBINATION THERAPY FOR CANCER TREATMENT
WO2003035614A2 (en) * 2001-10-25 2003-05-01 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2003035616A2 (en) * 2001-10-25 2003-05-01 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2003035619A1 (en) * 2001-10-25 2003-05-01 Merck & Co., Inc. Tyrosine kinase inhibitors
AU2002346457A1 (en) * 2001-11-21 2003-06-10 Pharmacia And Upjohn Company Pharmaceutical formulations comprising indolinone derivatives
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
CA2470480C (en) 2001-12-27 2010-12-14 Theravance, Inc. Indolinone derivatives useful as protein kinase inhibitors
TW200407124A (en) * 2002-06-25 2004-05-16 Wyeth Corp Use of thio-oxindole derivatives in treatment of hormone-related conditions
US7115649B2 (en) 2002-06-25 2006-10-03 Wyeth Methods of treating skin disorders using thio-oxindole derivatives
IL166528A0 (en) 2002-08-02 2006-01-15 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
US8450302B2 (en) 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
MXPA05003431A (en) * 2002-11-15 2005-07-05 Warner Lambert Co Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer.
ATE465731T1 (en) 2003-10-23 2010-05-15 Ab Science 2-AMINOARYLOXAZOLE COMPOUNDS AS TYROSINE KINASE INHIBITORS
CN100432071C (en) * 2004-11-05 2008-11-12 中国科学院上海药物研究所 Substituted 1H-indole-2-ketone compound and its preparation method and uses
MX2007012392A (en) 2005-04-04 2007-12-05 Ab Science Substituted oxazole derivatives and their use as tyrosine kinase inhibitors.
US8246966B2 (en) 2006-08-07 2012-08-21 University Of Georgia Research Foundation, Inc. Trypanosome microsome system and uses thereof
US8338433B2 (en) 2006-11-22 2012-12-25 University Of Georgia Research Foundation, Inc. Tyrosine kinase inhibitors as anti-kinetoplastid agents
AP3881A (en) * 2011-11-11 2016-10-31 Lilly Co Eli Combination therapy for ovarian cancer
EP3242934B1 (en) 2015-01-08 2021-08-18 The Board of Trustees of the Leland Stanford Junior University Factors and cells that provide for induction of bone, bone marrow, and cartilage
AU2016255434C1 (en) 2015-04-29 2021-09-23 Rapport Therapeutics, Inc. Azabenzimidazoles and their use as AMPA receptor modulators
CN105585558A (en) * 2015-12-15 2016-05-18 贵州大学 Double-alkoxy pyrimidine jointing 3-ethylenic-bond-oxoindole derivative and preparing method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
ES2251741T3 (en) * 1996-08-23 2006-05-01 Sugen, Inc. INDOLINONA COMBINATORY LIBRARIES AND RELATED PRODUCTS AND METHODS FOR THE TREATMENT OF DISEASES.

Also Published As

Publication number Publication date
WO2000038519A1 (en) 2000-07-06
JP2002533360A (en) 2002-10-08
AU760964B2 (en) 2003-05-22
EP1139754A4 (en) 2002-12-18
EP1139754A1 (en) 2001-10-10
KR20010108063A (en) 2001-12-07
MXPA01006742A (en) 2004-04-21
CA2357042A1 (en) 2000-07-06
AU2221500A (en) 2000-07-31
CN1356872A (en) 2002-07-03
BR9916735A (en) 2001-09-25

Similar Documents

Publication Publication Date Title
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
HUP0400887A3 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
IL138573A0 (en) Amide derivatives and pharmaceutical compositions containing the same
IL143799A0 (en) Phenoxyphenyl derivatives and pharmaceutical compositions containing the same
IL141456A0 (en) Rhodanine derivatives and pharmaceutical compositions containing the same
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL142665A0 (en) Acyl dipeptidyl derivatives and pharmaceutical compositions containing the same
IL135176A0 (en) Benzothiazole derivatives and pharmaceutical compositions containing the same
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
IL139479A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL135589A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
IL136941A0 (en) Sulphonamide derivatives and pharmaceutical compositions containing the same
IL136940A0 (en) Sulphonamide derivatives and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL138725A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
IL138572A0 (en) Benzoate derivatives and pharmaceutical compositions containing the same